Newer parameters of the octreotide test in patients with acromegaly-Reference-Cited by-同舟云学术

Newer parameters of the octreotide test in patients with acromegaly

Published:2023-11-24 Issue:1 Volume:27 Page:33-43
ISSN:1386-341X
Container-title:Pituitary
language:en
Short-container-title:Pituitary

Author:

Urai Shin,Yamamoto Masaaki^ORCID,Yamamoto Naoki,Suzuki Masaki,Shichi Hiroki,Kanie Keitaro,Fujita Yasunori,Bando Hironori,Fukuoka Hidenori,Takahashi Michiko,Iguchi Genzo,Takahashi Yutaka,Ogawa Wataru

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s11102-023-01362-z.pdf

Reference46 articles.

1. Fleseriu M, Langlois F, Lim DST et al (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10:804–826. https://doi.org/10.1016/S2213-8587(22)00244-3

2. Giustina A, Barkan A, Beckers A et al (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab 105:e937–e946. https://doi.org/10.1210/clinem/dgz096

3. Melmed S, Bronstein MD, Chanson P et al (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14:552–561. https://doi.org/10.1038/s41574-018-0058-5

4. Cuevas-Ramos D, Carmichael JD, Cooper O et al (2015) A structural and functional acromegaly classification. J Clin Endocrinol Metab 100:122–131. https://doi.org/10.1210/jc.2014-2468

5. Carmichael JD, Bonert VS, Nuño M et al (2014) Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis. J Clin Endocrinol Metab 99:1825–1833. https://doi.org/10.1210/jc.2013-3757